![](/img/cover-not-exists.png)
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft Models
Schuller, A. G., Barry, E. R., Jones, R. D. O., Henry, R. E., Frigault, M. M., Beran, G., Linsenmayer, D., Hattersley, M., Smith, A., Wilson, J., Cairo, S., Deas, O., Nicolle, D., Adam, A., Zinda, M.,Volume:
21
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-2685
Date:
June, 2015
File:
PDF, 5.83 MB
english, 2015